AramZabetiMD
Neurology • Cincinnati, OHNeuroimmunology/Multiple Sclerosis
Assistant Professor of Neurology University of Cincinnati Director and Endowed Chair Waddell Center for Multiple Sclerosis
Dr. Zabeti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3113 Bellevue Ave
Fl 3
Cincinnati, OH 45219Phone+1 513-475-8730Fax+1 513-475-8033
Education & Training
Oregon Health & Science UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
West Virginia UniversityResidency, Neurology, 2009 - 2012- West Virginia UniversityInternship, Transitional Year, 2008 - 2009
Azad UniversityClass of 1999
Certifications & Licensure
OR State Medical License 2012 - Present
KY State Medical License 2015 - 2026
CA State Medical License 2017 - 2025
OH State Medical License 2013 - 2025
WV State Medical License 2011 - 2013
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United States.Giovanna Sophia Manzano, James Eaton, Michael Levy, Justin R Abbatemarco, Allen J Aksamit
Neurology. Clinical Practice. 2025-04-01 - Association between diffusion tensor imaging measurements and cognitive performances in people with multiple sclerosis: A systematic review and meta-analysis.Omid Mirmosayyeb, Mohammad Yazdan Panah, Saeed Vaheb, Hamed Ghoshouni, Farhad Mahmoudi
Multiple Sclerosis and Related Disorders. 2025-02-01 - Abnormal body mass index is associated with risk of multiple sclerosis: A systematic review and meta-analysis.Mohammad Mohammadi, Aynaz Mohammadi, Adrina Habibzadeh, Rojin Korkorian, Mobin Mohamadi
Obesity Research & Clinical Practice. 2024-11-29
Journal Articles
- Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisAram Zabeti, MD, The New England Journal of Medicine
Press Mentions
Cincinnati Plays Role in Breakthrough Multiple Sclerosis StudyAugust 30th, 2018
Multiple Sclerosis Drug Slows Brain Shrinkage, Study ShowsAugust 29th, 2018
Strikeout MS Founders Present $25,000 to UC's Waddell CenterApril 20th, 2018
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
